The guidelines for diagnosis and treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma in China（2025）

TL;DR

This paper presents updated Chinese guidelines for diagnosing and treating chronic lymphocytic leukemia/small lymphocytic lymphoma in 2025.

Contribution

The paper provides revised and updated diagnostic and treatment guidelines for CLL/SLL in China.

Findings

Recent advances in basic and clinical research, especially in new drug therapies, have been incorporated into the guidelines.

The guidelines aim to improve the diagnostic and treatment standards for CLL/SLL among medical professionals in China.

Abstract

慢性淋巴细胞白血病（CLL）/小淋巴细胞淋巴瘤（SLL）是主要发生在中老年人群的、具有特殊免疫表型的成熟B淋巴细胞克隆增殖性肿瘤。近年来，CLL/SLL的基础与临床研究，特别是新药治疗领域取得了巨大进展。为提高我国医务工作者对CLL/SLL的诊断、鉴别诊断及规范化治疗水平，中国抗癌协会血液肿瘤专业委员会、中华医学会血液学分会和中国慢性淋巴细胞白血病工作组对中国CLL/SLL的诊断与治疗指南（2022年版）进行了修订，制订了本版指南。